These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 10831347)

  • 1. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
    Fülöp V; Végh G; Doszpod J
    Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
    J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
    Cameron B; Gown AM; Tamimi HK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1616-21; discussion 1621-2. PubMed ID: 7911272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
    Wong SY; Ngan HY; Chan CC; Cheung AN
    Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
    Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
    Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
    Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of gestational trophoblastic neoplasia: a review.
    Fulop V; Mok SC; Berkowitz RS
    J Reprod Med; 2004 Jun; 49(6):415-22. PubMed ID: 15283047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta.
    Tseng JJ; Hsu SL; Wen MC; Ho ES; Chou MM
    Am J Obstet Gynecol; 2004 Dec; 191(6):2106-13. PubMed ID: 15592299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
    Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
    J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.
    Bozić M; Petronijević M; Milenković S; Atanacković J; Lazić J; Vićovac Lj
    Placenta; 2004 Nov; 25(10):797-802. PubMed ID: 15451194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understandings of the molecular genetics of gestational trophoblastic diseases.
    Li HW; Tsao SW; Cheung AN
    Placenta; 2002 Jan; 23(1):20-31. PubMed ID: 11869089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.